Interesting data are emerging from the Indian weight-loss drug market this March. Mounjaro, containing the molecule tirzepatide, Eli Lilly’s weight-loss drug, appears to be losing some ground as ...

TORONTO - Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...

After manufacturing the antibiotic Rocephin for four decades—and developing it into one of the company’s first blockbuster medicines—Roche is looking to divest the treatment and its production ...

Every shopper has faced the dilemma: do you grab the cheaper store brand or stick with the familiar name brand? With grocery prices climbing, the choice between saving money and ensuring quality feels ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

java-core project provides vast interview programs, Real time implementation, Exceptions, regular expressions, collections, oops concepts ect. Here you can gain the knowledge about java syntax, ...

NEW YORK – Novartis is optimistic that revenue from its blockbusters and therapies resulting from new acquisitions, including a recent $12 billion bid for the mRNA therapeutics company Avidity ...

This annual observance highlights the importance of generic medicines in providing affordable, effective and accessible healthcare to Filipinos. It was held under the theme “Ginhawang Generics, Ramdam ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

The EU’s General Court struck down Biogen’s extra year of market protection for Tecfidera, siding with generics in a ruling that could speed cheaper multiple sclerosis drugs to patients. (CN) — ...